Home Tags Medtronic

Medtronic

Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy: Published in New England Journal of Medicine

Medtronic Ranked as a Leading Sustainability Company

In-Pen

In-Pen with Real-Time Connect CGM Data: 1st Integrated Smart Insulin Pen for People with Diabetes on Multiple Daily Injections

Abre Venous Self-Expanding Stent System Receives FDA Approval Reports Medtronic

DTM Spinal Cord Stimulation 12 Month Study Results Reported by Medtronic

First Patient Implanted in ELITE Study of InterStim Micro System

Resolute Onyx Drug Eluting Stent Receives FDA Approval for New 1 Month DAPT Labeling With Expanded Indication for HBR Patients Implanted with the Resolute Onyx™ DES

Medtronic Receives Breakthrough Device Designation from FDA

MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives FDA Approval

Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

1234Page 2 of 4
© Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc.
Exit mobile version